Vitt Revenue and Competitors

London,

Location

$15M

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Vitt's estimated annual revenue is currently $105k per year.(i)
  • Vitt's estimated revenue per employee is $21,000
  • Vitt's total funding is $15M.

Employee Data

  • Vitt has 5 Employees.(i)
  • Vitt grew their employee count by -17% last year.

Vitt's People

NameTitleEmail/Phone
1
Head Finance and Capital MarketsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$106.8M407-12%N/AN/A
#2
$220.4M734-1%$13.6MN/A
#3
$23.1M110-2%N/AN/A
#4
$727.9M247610%N/AN/A
#5
$40M17320%N/AN/A
#6
$26.7M1274%N/AN/A
#7
$19.1M91-12%N/AN/A
#8
$11.2M595%N/AN/A
#9
$22.3M10661%N/AN/A
#10
$20.6M98-21%N/AN/A
Add Company

What Is Vitt?

Right now, if SaaS founders want money, they have to pitch VCs (who typically haven't even worked for a startup) or try (and fail) to get money from banks. With Vitt, get upfront, non-dilutive financing against your monthly recurring revenues. Never trade growth off against dilution again.

keywords:N/A

$15M

Total Funding

5

Number of Employees

$105k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vitt News

2022-04-17 - A Rare Case of COVID-19 Vaccine-Induced Thrombotic ...

VITT syndrome which mimics autoimmune heparin-induced thrombocytopenia (AHIT), has a distinctive feature of thrombosis in unusual sites...

2022-04-06 - Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

VITT is an uncommon thromboembolic event facilitated by Abs targeting platelet factor 4 (PF4) in adenoviral-vectored severe acute...

2022-03-22 - Vaccine-Induced Thrombotic Thrombocytopenia: A Case of ...

VITT has a predilection to cause thrombosis in cerebral venous sinuses, followed by splanchnic veins, particularly the portal vein, all of which...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M5-37%$25M
#2
$0.4M50%$7M
#3
$0.3M525%N/A
#4
$0.5M5-58%N/A
#5
$0.4M5-17%N/A